Venture capital firm based in Sheffield, UK
Cambridge-based biotech firm, Tenpoint Therapeutics, secures $70M in Series A funding to advance regenerative medicine platform and restore vision for individuals with degenerative ocular diseases. Read more
Curve Therapeutics, backed by $40.5M in funding from industry giants like Pfizer Ventures, is revolutionizing drug discovery to tackle complex diseases and push the boundaries of biotechnology. Read more
Phagenesis secures $42M in funding to revolutionize treatment for swallowing dysfunction, poised to expand globally with groundbreaking neurostimulation system. Read more
Wagestream secures £17.5M in funding to revolutionize financial benefits for low and middle-income workers, offering innovative services like credit-builder cards and AI-powered financial coaching. Read more
Epsilogen is revolutionizing cancer treatment with groundbreaking IgE antibodies and a £12.5 million boost in funding, propelling them towards a potential game-changer for patients battling solid tumors! Read more
Purespring Therapeutics is charging ahead with a groundbreaking $105 million funding boost to redefine kidney disease treatment, starting with an innovative trial for IgA Nephropathy that could change the lives of millions! Read more
Nuclera secures $75 million in Series C funding to revolutionize protein production and streamline drug discovery, setting the stage for a biotech breakthrough! Read more
Biotech | 50.0% |
Healthtech | 37.5% |
AI | 12.5% |